Assessment of mitochondrial function in metabolic dysfunction-associated fatty liver disease using obese mouse models
Metabolic dysfunction-associated fatty liver disease (MAFLD) is characterized by deregulated hepatic lipid metabolism; however, the association between MAFLD development and mitochondrial dysfunction has yet to be confirmed. Herein, we employed high-resolution respirometry, blue native polyacrylamid...
Main Authors: | Qiong-Ya Zhao, Ling-Hong Ge, Kun Zhang, Hai-Feng Chen, Xin-Xin Zhan, Yue Yang, Qing-Lin Dang, Yi Zheng, Huai-Bin Zhou, Jian-Xin Lyu, He-Zhi Fang |
---|---|
Format: | Article |
Language: | English |
Published: |
Science Press, PR China
2020-09-01
|
Series: | Zoological Research |
Subjects: | |
Online Access: | http://www.zoores.ac.cn/EN/10.24272/j.issn.2095-8137.2020.051 |
Similar Items
-
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Published: (2013-12-01) -
Obesity-related non-alcoholic steatohepatitis and TGF-β1 serum levels in relation to morbid obesity
by: Ricardo N Sepúlveda-Flores, MD, et al.
Published: (2002-01-01) -
Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?
by: Agostino Di Ciaula, et al.
Published: (2021-05-01) -
Irinotecan-Induced Steatohepatitis: Current Insights
by: Jun Han, et al.
Published: (2021-10-01) -
Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
by: Cristiane V. Tovo, et al.
Published: (2019-05-01)